AVAI BIO, INC.
OTC · CIK 0001740797 · Fiscal year end 0331
Latest reported period: Latest published period
Operating Income
$-1.7M
Net Income
$-1.7M
Eps Basic
-0.01
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.7M | - | - |
| Net Income | $-1.7M | - | - |
| Eps Basic | -0.01 | - | - |
| Cash And Equivalents | $23,145 | - | - |
| Total Assets | $572,696 | - | - |
| Total Liabilities | $3.4M | - | - |
| Shareholders Equity | $-2.8M | - | - |
| Operating Cash Flow | $-1.0M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-K | AVAI BIO, INC. | 2026-07-14 | 0001740797-26-000017 |
| 10-Q | AVAI BIO, INC. | 2026-02-12 | 0001740797-26-000009 |
| 10-Q | AVAI BIO, INC. | 2025-11-14 | 0001740797-25-000054 |
| 10-Q | AVAI BIO, INC. | 2025-08-12 | 0001740797-25-000043 |